Galectin Therapeutics Statistics Share Statistics Galectin Therapeutics has 63.29M
shares outstanding. The number of shares has increased by 1.63%
in one year.
Shares Outstanding 63.29M Shares Change (YoY) 1.63% Shares Change (QoQ) 1.58% Owned by Institutions (%) 15.65% Shares Floating 43.41M Failed to Deliver (FTD) Shares 42,564 FTD / Avg. Volume 6.61%
Short Selling Information The latest short interest is 7.7M, so 12.16% of the outstanding
shares have been sold short.
Short Interest 7.7M Short % of Shares Out 12.16% Short % of Float 20.41% Short Ratio (days to cover) 20.96
Valuation Ratios The PE ratio is -1.71 and the forward
PE ratio is -6.38.
Galectin Therapeutics's PEG ratio is
-0.63.
PE Ratio -1.71 Forward PE -6.38 PS Ratio 0 Forward PS 1.4 PB Ratio -0.78 P/FCF Ratio -1.92 PEG Ratio -0.63
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Galectin Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.49,
with a Debt / Equity ratio of -1.03.
Current Ratio 0.49 Quick Ratio 0.49 Debt / Equity -1.03 Debt / EBITDA -2.56 Debt / FCF -2.54 Interest Coverage -7.66
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.14M Employee Count 15 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 82.46% in the
last 52 weeks. The beta is 0.83, so Galectin Therapeutics's
price volatility has been higher than the market average.
Beta 0.83 52-Week Price Change 82.46% 50-Day Moving Average 2.45 200-Day Moving Average 1.88 Relative Strength Index (RSI) 82.73 Average Volume (20 Days) 643,806
Income Statement
Revenue n/a Gross Profit n/a Operating Income -42.43M Net Income -47.05M EBITDA -41.47M EBIT -41.51M Earnings Per Share (EPS) -0.76
Full Income Statement Balance Sheet The company has 15.12M in cash and 106.25M in
debt, giving a net cash position of -91.13M.
Cash & Cash Equivalents 15.12M Total Debt 106.25M Net Cash -91.13M Retained Earnings -401.57M Total Assets 9.53M Working Capital -101.56M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -41.77M
and capital expenditures 0, giving a free cash flow of -41.77M.
Operating Cash Flow -41.77M Capital Expenditures n/a Free Cash Flow -41.77M FCF Per Share -0.67
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields GALT does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for GALT is $6,
which is 55.8% higher than the current price. The consensus rating is "Buy".
Price Target $6 Price Target Difference 55.8% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 23, 2012. It was a
backward
split with a ratio of 1:6.
Last Split Date Mar 23, 2012 Split Type backward Split Ratio 1:6
Scores Altman Z-Score -82.77 Piotroski F-Score 2
